BCTXZ Stock Summary and Trading Ideas (Briacell Therapeutics Corp. - Warrant | NASDAQ:BCTXZ)

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Briacell Therapeutics Corp. - Warrant trades on the NASDAQ stock market under the symbol BCTXZ.

As of August 5, 2026, BCTXZ stock price was flat at $0.09 with 119,084 million shares trading.

BCTXZ has a beta of 3.40, meaning it tends to be more sensitive to market movements. BCTXZ has a correlation of 0.10 to the broad based SPY ETF.

BCTXZ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.

BCTXZ has underperformed the market in the last year with a price return of -72.0% while the SPY ETF gained +23.2%. BCTXZ has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.7% and -13.1%, respectively, while the SPY returned +7.5% and +2.9%, respectively.

BCTXZ support price is $.08 and resistance is $.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCTXZ shares will trade within this expected range on the day.